Cargando…
Nanopharmaceuticals (part 1): products on the market
In 2000, the National Institute of Health launched the National Nanotechnology Initiative to support, coordinate, and advance research and development of nanoscale projects. The impact of this new program on health-science related research and development became quickly visible. Broad governmental f...
Autores principales: | Weissig, Volkmar, Pettinger, Tracy K, Murdock, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172146/ https://www.ncbi.nlm.nih.gov/pubmed/25258527 http://dx.doi.org/10.2147/IJN.S46900 |
Ejemplares similares
-
Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig, Volkmar, et al.
Publicado: (2015) -
Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
por: Souto, Eliana B., et al.
Publicado: (2020) -
Nanopharmaceutics
por: Ali, Javed
Publicado: (2011) -
Trends in Nanopharmaceutical Patents
por: Antunes, Adelaide, et al.
Publicado: (2013) -
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)